Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year—Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS)

AIM: Optimal revascularization strategy in multivessel (MV) coronary artery disease (CAD) eligible for percutaneous management (PCI) and surgery remains unresolved. We evaluated, in a randomized clinical trial, residual myocardial ischemia (RI) and clinical outcomes of MV-CAD revascularization using...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganyukov, Vladimir, Kochergin, Nikita, Shilov, Aleksandr, Tarasov, Roman, Skupien, Jan, Szot, Wojciech, Kokov, Aleksandr, Popov, Vadim, Kozyrin, Kirill, Barbarash, Olga, Barbarash, Leonid, Musialek, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961598/
https://www.ncbi.nlm.nih.gov/pubmed/31969796
http://dx.doi.org/10.1155/2020/5458064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961598/
https://www.ncbi.nlm.nih.gov/pubmed/31969796
http://dx.doi.org/10.1155/2020/5458064

Ejemplares similares